ASTH vs HCA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and HCA is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 0 FA rating(s) are green whileHCA’s FA Score has 3 green FA rating(s).
- ASTH’s FA Score: 0 green, 5 red.
- HCA’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 4 TA indicator(s) are bullish while HCA’s TA Score has 3 bullish TA indicator(s).
- ASTH’s TA Score: 4 bullish, 6 bearish.
- HCA’s TA Score: 3 bullish, 5 bearish.
Price Growth
ASTH (@Medical/Nursing Services) experienced а -29.55% price change this week, while HCA (@Medical/Nursing Services) price change was +0.16% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.23%. For the same industry, the average monthly price growth was +0.62%, and the average quarterly price growth was +1650.69%.
Reported Earning Dates
ASTH is expected to report earnings on Feb 20, 2025.
HCA is expected to report earnings on Feb 04, 2025.
Industries' Descriptions
@Medical/Nursing Services (-2.23% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ASTH | HCA | ASTH / HCA | |
| Capitalization | 1.88B | 88.2B | 2% |
| EBITDA | 124M | 12.7B | 1% |
| Gain YTD | 9.426 | 29.786 | 32% |
| P/E Ratio | 32.55 | 17.40 | 187% |
| Revenue | 1.39B | 65B | 2% |
| Total Cash | 296M | 935M | 32% |
| Total Debt | 321M | 41.9B | 1% |
ASTH | HCA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 70 | 12 | |
SMR RATING 1..100 | 69 | 45 | |
PRICE GROWTH RATING 1..100 | 61 | 53 | |
P/E GROWTH RATING 1..100 | 85 | 33 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HCA's Valuation (7) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (68) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.
HCA's Profit vs Risk Rating (12) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (70) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.
HCA's SMR Rating (45) in the Hospital Or Nursing Management industry is in the same range as ASTH (69) in the null industry. This means that HCA’s stock grew similarly to ASTH’s over the last 12 months.
HCA's Price Growth Rating (53) in the Hospital Or Nursing Management industry is in the same range as ASTH (61) in the null industry. This means that HCA’s stock grew similarly to ASTH’s over the last 12 months.
HCA's P/E Growth Rating (33) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (85) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.
| ASTH | HCA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 63% | 3 days ago 74% |
| Stochastic ODDS (%) | 3 days ago 76% | 3 days ago 67% |
| Momentum ODDS (%) | 3 days ago 73% | 3 days ago 64% |
| MACD ODDS (%) | 3 days ago 72% | 3 days ago 49% |
| TrendWeek ODDS (%) | 3 days ago 73% | 3 days ago 70% |
| TrendMonth ODDS (%) | 3 days ago 75% | 3 days ago 59% |
| Advances ODDS (%) | 10 days ago 0% | N/A |
| Declines ODDS (%) | 3 days ago 71% | 3 days ago 55% |
| BollingerBands ODDS (%) | 3 days ago 71% | 3 days ago 86% |
| Aroon ODDS (%) | 3 days ago 81% | N/A |
ASTH and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with AMN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then AMN could also see price increases.
| Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
|---|---|---|---|---|
| ASTH | 100% | -2.33% | ||
| AMN - ASTH | 50% Loosely correlated | -5.71% | ||
| AGL - ASTH | 50% Loosely correlated | +0.53% | ||
| CCRN - ASTH | 46% Loosely correlated | -8.43% | ||
| ENSG - ASTH | 42% Loosely correlated | -0.21% | ||
| SGRY - ASTH | 36% Loosely correlated | -13.75% | ||
More | ||||
HCA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCA has been closely correlated with UHS. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then UHS could also see price increases.